Hello, Reader. For all that artificial intelligence has accomplished over the last few years, one thing it has not yet ...

Read the article by Lorne Patterson and Myrrh Winston on the development of electrophysiological treatment for substance use ...

demonstrated by his recent leadership in the approval of the first novel schizophrenia treatment in decades ... at 07:05 Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug ...

AbbVie (NYSE:ABBV) shares snapped eight consecutive sessions of losses as the stock closed up 0.78% at $166.28. The North ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency.

The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...

In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...

Neurelis, Inc., today announced it will participate in the 12th Annual Sofie's Journey Epilepsy Awareness Day & Education Expo at Disneyland (EADDL), one of the largest gatherings of people with ...